Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of SyB L-0501 in combination with
rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.